Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Jul 29.

Published in final edited form as: Cancer Res. 2009 Aug 25;69(17):6932–6940. doi: 10.1158/0008-5472.CAN-09-1682

Table 3.

Tumor to tissue ratios of [¹²³I]MIP-1072, [¹²³I]MIP-1095, and ProstaScint™ in NCr nude mice bearing LNCaP xenografts.

		Time (hr)
	Ratio	0.25	1	2	4	8	24
[¹²³I]MIP-1072	Tumor:Blood	4.97	37.1	65.4	220	176	411
	Tumor:Skeletal Muscle	16.2	50.0	70.2	182	446	64.5
[¹²³I]MIP-1095	Tumor:Blood	2.10	10.6	24.3	40.6	57.5	174
	Tumor:Skeletal Muscle	8.79	49.3	80.8	133	121	304

		Time (hr)
	Ratio	1	4	24	48	72

ProstaScint™	Tumor:Blood	0.11	0.27	1.41	2.37	2.92
	Tumor:Skeletal Muscle	3.93	12.0	22.8	33.1	41.2

Data are ratios based on the %ID/g.